Fiscal Year 2001 President's Budget Request for the National Cancer Institute
(2/15/00)

Statement of Richard D. Klausner, M.D., Director, National Cancer Institute before the House Subcommittee on Labor-HHS-Education Appropriations.

NIH and E.I. DuPont Sign OncoMouse® Agreement
(1/19/00)

HPV Testing May Be Useful in Cervical Cancer Screening
(1/4/00)

NCI-Sponsored Trials of Celecoxib for Cancer Prevention
(1/3/00)

NCI Establishes Consortium to Develop Mouse Models of Human Cancers
(12/28/99)

NCI Expands Office of Cancer Survivorship Web Site
(12/14/99)

The National Cancer Institute Publishes New Atlas of Cancer Mortality
(12/08/99)

 Questions and Answers for Atlas of Cancer Mortality in the United States, 1950-94

El Instituto Nacional del Cáncer publica nuevo atlas de mortalidad por cáncer

NCI Awards First Grants for the Director's Challenge
(12/03/99)

Environmental Tobacco Smoke Linked to Lung Cancer and Other Health Effects
(11/22/99)

NCI Announces Major Enhancements to CancerNet^TM Web Site
(11/17/99)

Scientists Report First Responses in Cancer Patients to A Recombinant Immunotoxin
(11/8/99)

Weighing the Risks and Benefits of Tamoxifen to Reduce Risk of Breast Cancer
(11/2/99)

Misconceptions Persist Among Older Women In Spite Of Rising Mammography Rates 
(10/20/99)

Federal Institutes and The Robert Wood Johnson Foundation Create Tobacco Use Research Centers 
(10/18/99)

NCI Awards First Contracts for Unconventional Innovations Program 
(10/8/99)

NCI Announces SPORE Grants for Ovarian Cancer Research 
(10/7/99)

NCI Begins Funding Early Detection Research Network: 18 Biomarker Developmental Laboratories Seek Tests for Common Cancers 
(10/6/99)

Monitoring NCI-Sponsored Clinical Trials 
(10/4/99)

United States and Ireland Establish Historic Cancer Collaboration 
(10/3/99)

Lymphoma Vaccine Enters Large-Scale Clinical Trials 
(9/27/99)

NCI Assists Establishment of DNA Microarray Facilities 
(9/21/99)

NCI Assists Establishment of DNA Microarray Facilities 
(9/21/99)

NCI's Role in the Development of Endostatin 
(9/15/99)

New Study Will Assess Colorectal Cancer Screening Practices 
(9/8/99)

Monograph Highlights Research in Native American Populations 
(8/26/99)

NCI's Tumor Gene Index Reaches Its Two-Year Mark 
(8/10/99)

NCI's Division of Clinical Sciences Will Test Thalidomide in Patients with Advanced Colon Cancer 
(8/6/99)

NCI Leases New Supercomputer 
(8/2/99)

HMO Research Network Receives NCI Funding to Establish Cancer Research Network 
(7/20/99)

Dinah Singer Named New Director of NCI's Division of Cancer Biology 
(7/19/99)

NCI Will Test New Drugs for Colorectal Cancer Throughout North America 
(6/30/99)

Scientists Suggest New Approaches for Development of AIDS Drugs and Vaccines 
(6/21/99)

Publication of the MORE Trial Results Supports Study of Tamoxifen and Raloxifene 
(6/15/99)

Breast Cancer Prevention Study Seeks Volunteers: Study of Tamoxifen and Raloxifene (STAR) Under Way Across North America 
(5/25/99)

 Estudio para la prevención del cáncer necesita voluntarias: El Estudio del Tamoxifeno y Raloxifeno (STAR) se realiza en Norteamérica
5/25/99
Preguntas y respuestas acerca del Estudio del Tamoxifeno y Raloxifeno (STAR)
5/25/99Declaración de la Secretaria del Departamento de Salud y Servicios Humanos de los Estados Unidos, Donna E. Shalala, acerca del Estudio de Tamoxifeno y Raloxifeno 
5/25/99Link

 Visit the CancerTrials STAR home page. 

NCI Statement: High-Dose Chemotherapy/Bone Marrow Transplant Studies for Breast Cancer 
(3/10/99)

The National Cancer Institute (NCI) is sponsoring studies of the effectiveness of high-dose chemotherapy and autologous bone marrow or stem cell transplantation in the treatment of breast cancer. Preliminary results of two of these will be presented at the May meeting of the American Society of Clinical Oncology (ASCO). The results of two similar foreign studies will also be presented at the meeting. 

See Press Release and cancerTrials: Statements from Other Organizations.

NCI Issues Clinical Announcement on Cervical Cancer: Chemotherapy Plus Radiation Improves Survival 
(2/22/99)

The National Cancer Institute (NCI) sent a clinical announcement to thousands of physicians stating that strong consideration should be given to adding chemotherapy to radiation therapy in the treatment of invasive cervical cancer. 

(Also see Press Release and Cervical Cancer Backgrounder).

NCI Opens the Scholars Program for Applications
(12/1/98)

NCI is inviting applications for the Scholars Program. The Scholars Program provides new investigators with resources to establish their first independent cancer research program within the interactive environment of the Intramural research program at the NCI. Application deadline: March 22, 1999. 

For more information: Scholars Program Homepage

The Nation's Investment in Cancer Research: A Budget Proposal for Fiscal Year 2000
(12/1/98)

Each year, the NCI prepares this document to inform the President, the Congress, and through them, the American people about its progress against cancer, its vision of new opportunities that promise to greatly advance our understanding of this disease and the resources that will enable the NCI to pursue the most promising avenues of research rapidly and efficiently. 

For more information: Budget Proposal

Tobacco Research Implementation Plan: Priorities for Tobacco Research Beyond the Year 2000 
(11/19/98)

Tobacco-related cancers exact an enormous toll on the Nation’s public health. More than 30 percent of all cancer deaths are caused by tobacco use. The Tobacco Research Implementation Plan is the product of a 7 month process of fact-finding and deliberation by leading scientists within and outside the NCI. It will guide the implementation of a program of tobacco-related research which will help to reduce the sizable health toll caused by tobacco use.

Rapid Access To Intervention Development "RAID" 
(10/19/98)

RAID is a new program designed to facilitate translation to the clinic of novel, scientifically meritorious therapeutic interventions originating in the academic community. It will do this by making available to the academic research community, on a competitive basis, NCI resources for the pre-clinical development of drugs and biologics. See the Developmental Therapeutics Program Home Page for more information.

A New Clinical Oncology Special Emphasis Panel (SEP) will be Formed for Applications Received Beginning October 1, 1998
(9/15/98)

A description is available at http://www.drg.nih.gov/review/clinonc.htm. Comments are encouraged and can be sent to Jean K. Paddock, Ph.D. at Paddockj@drg.NIH.GOV. The comment period will end September 25, 1998.

National Academy of Sciences' Institute of Medicine (IOM) Releases Report on Exposure to I-131 Fallout during Nuclear Testing
(9/2/98)

Following up on the 1997 NCI study of American's exposure to I-131 from atomic bomb test fallout, the IOM has released a report assessing medical and public health implications of the study. The IOM report also provides recommendations for education and clinical practice. Information about this report is available on the National Academy of Sciences Website. 

Archived and still available on the Website are materials released in 1997 about the NCI study.

NCI Announces the Availability of the Prostate Cancer Progress Review Group Report and the Breast Cancer Progress Review Group Report 
(9/2/98)

In 1997, The NCI convened Progress Review Groups in the areas of Prostate Cancer and Breast Cancer. These groups were charged with assessing the status of the research funded by NCI in each area and providing to the NCI priorities and recommendations to maximally advance research in these areas. 

The final report of each group is now available:

• Defeating Prostate Cancer: Crucial Directions for Prostate Cancer Research 
• Charting the Course: Priorities for Breast Cancer Research 

NCI Announces the Unconventional Innovations Program
(8/21/98)

The Unconventional Innovations Program (UIP) will implement a new approach to funding the development of high impact, long range technologies to support cancer research. The UIP will focus on the development of technology platforms that can couple the relatively non-invasive sensing and signaling of specific molecular alterations in patients with capabilities for controlled and monitorable intervention specific for these molecular alterations. Ideas from researchers will contribute to the general scope of a Broad Agency Agreement (BAA) to be issued in late 1998 or early 1999.

NCI Statement 
on the Status of the Integration of Complementary and 
Alternative Medicine (CAM) and Cancer
(7/31/98)

The National Cancer Institute released a Statement of Richard D. Klausner, M.D., Director, National Cancer Institute before the House Government Reform and Oversight Committee. 

• Statement 

NCI Statement 
on Endostatin and Angiostatin
(5/4/98)

The National Cancer Institute released a statement concerning the results of the animal studies on endostatin and angiostatin by researchers at Boston's Children's Hospital and Harvard Medical School. 

• Q & A About Anti-Angiogenesis Research 

AIDS Malignancy Meeting Summaries Now Available
(4/22/98)

Online, lay-language summaries for major presentations at Second National AIDS Malignancy Conference are now available at http://healthcg.com/hiv/2ndnciconf. Experts discuss the sharp drop in Kaposi’s sarcoma rates, emerging treatments and detection strategies, and findings concerning viruses linked to AIDS-related cancers. The NCI Conference was held April 6-8.

Breast Cancer Prevention Trial Statement
(4/21/98)

Statement of Richard D. Klausner, M.D., Director, National Cancer Institute before the Senate Appropriations Subcommittee on Labor, Health, Human Services and Related Agencies

New Report on Cigar Smoking Released by NCI 
(4/10/98)

A new NCI report, Cigars: Health Effects and Trends, shows that daily cigar smoking causes cancers of the the lip, tongue, mouth, throat, larynx, esophagus, and lung, as well as chronic obstructive pulmonary (lung) disease and coronary heart disease. 

• press release 
• background information 
• charts and graphs 
• organizations with information about cigar smoking 
• full report 

Breast Cancer Prevention Trial Shows Major Benefit (4/6/98)

Six Years after its inception, the Breast Cancer Prevention Trial (BCPT) shows a 45 percent reduction in breast cancer incidence among high-risk women who took tamoxifen. 

• press release 
• charts and graphs 
• Questions and Answers: The Breast Cancer Prevention Trial (BCPT) 

Clinical Trials Resource Center Now Online
(4/6/98)

NCI introduces http://cancertrials.nci.nih.gov, a comprehensive online resource center for clinical trials information for cancer patients and health professionals.

The Nation's Investment in Cancer Research: A Budget Proposal for Fiscal Year 1999
(3/26/98)

Each year, the NCI prepares this document to inform the President, the Congress, and through them, the American people about its progress against cancer, its vision of new opportunities that promise to greatly advance our understanding of this disease and the resources that will enable the NCI to pursue the most promising avenues of research rapidly and efficiently. 

• Strategic Planning at the National Cancer Institute 

FY 1999 President's Budget Request Presented to Congress
(3/25/98)

NCI Director Richard D. Klausner presents the President's proposed NCI budget of $2.536 billion for FY 1999. This budget will allow for both continued and accelerated progress in cancer research reflected in last year's announcement of the first significant drop in cancer incidence and mortality rates. 

• full statement 

NCI Introduces New Legislative Activities Web Site
(3/25/98)

NCI's Office of Legislation and Congressional Activities introduces its new homepage. Learn about recent events, hearings, and legislation relating to cancer research.

Cancer Incidence and Death Rates Decline
(3/12/98)

Cancer incidence and death rates for all cancers combined and for most of the top 10 cancer sites declined between 1990 and 1995, reversing an almost 20-year trend of increasing cancer cases and deaths in the United States. A scientific paper on the topic, "Cancer Incidence and Mortality, 1973-1995" was published in the March 15, 1998 issue of CANCER. 

• Press Release 
• Questions and Answers on Cancer Rates 
• Graphs showing incidence and mortality 

RFA and Program Announcement Concepts Now Available on the Web
(3/9/98)

Concepts for: 1) new Requests for Applications (RFAs), cleared at the NCI Board of Scientific Advisors and 2) new program announcements and re-issued RFAs, now are available on the web. This information provides potential applicants with an early alert to upcoming publication of these initiatives. See Recently Cleared Concepts.